4 курс / Акушерство и гинекология / Гугушвили_Н_А_Клинико_патогенетическое_обоснование_тактики_ведения

1983. – Vol. 221 – P. 236–240.

225.Seeds J.W. Impaired fetal growth: ultrasonic evaluation and clinical management // Obstet Gynecol. – 1984. – Vol. 64 – №4 – P. 577-584.

226.Semczuk-Sikora A., Krzyzanowski A., Kwiatek M., Semczuk M. Maternal serum concentration of placental growth factor (PIGF) and endothelial growth factor (VEGF) in pregnancies complicated by preeclampsia // Ginekol Pol. – 2007. – Vol. 78 – №11 – P. 873-876.

227.Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid // Science. – 1983 – Vol. 219 – №4587 – P. 983-985.

228.Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice // Nature. – 1995. – Vol. 376 – №6535 – P. 62 – 66.

229.Shore V.H., Wang T.H., Wang C.L., Torry R.J., Caudle M.R., Torry D.S. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast // Placenta. 1997. – Vol. 18 – P. 657–665.

230.Sibai B.M. Thrombophilias and adverse outcomes of pregnancy – what should a clinician do? // N Engl J Med. – 1999 – Vol. 340 – №1 – P. 50-52.

231.Sinclair J.C. Meta-analysis of randomized controlled trials of antenatal corticosteroid for prevention of respirstory distress syndrome (discission) // Am J Obstet Gynecol – 1995 – Vol. 173 – P. 335-344.

232.Sivan E., Dulitzky M., Lipitz S., Hamiel-Pinchas O., Reichman B., Mashiach S., Achiron R. The clinical value of umbilical artery Doppler velocimetry in the management of intrauterine growth-retarded fetuses before 32 weeks' gestation // Gynecol Obstet Invest. – 1995. – Vol. 40 – №1 P. 19-23.

171

233.Soothill P.W., Bobrow C.S., Holmes R. Small for gestational age is not a diagnosis // Ultrasound Obstet Gynecol. – 1999 – Vol. 13 – №4 – P. 225228.

234.Stein A. J. Pregnancy in gravidas over age 35 years. // Nurse Midwifery. – 1983. – Vol. 28 – №1 – P. 17-20.

235.Sterne G., Shields L.E., Dubinsky T.J. Abnormal fetal cerebral and umbilical Doppler measurements in fetuses with intrauterine growth restriction predicts the severity of perinatal morbidity // J Clin Ultrasound. – 2001 – Vol. 29 – №3 – P. 146-51.

236.Strauss R.S. Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort // JAMA 2000. – Vol. 283 – №5 – P. 625-632.

237.Supplementation with Multiple Micronutrients Intervention Trial (SUMMIT) Study Group, Shankar A.H., Jahari A.B., Sebayang S.K., Aditiawarman, Apriatni M., Harefa B., Muadz H., Soesbandoro S.D., Tjiong R., Fachry A., Shankar A.V., Atmarita, Prihatini S., Sofia G. Effect of maternal multiple micronutrient supplementation on fetal loss and infant death in Indonesia: a double-blind cluster-randomised trial // Lancet. – 2008.

– Vol. 371 – №9608 – P. 215–227.

238.Toal M., Keating S., Machin G., et al. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images // Am J Obstet Gynecol 2008. – Vol. 198 – №3 – P. 330 – 337.

239.Torry D.S., Wang H.S., Wang T.H., Caudle M.R., Torry R.J. Preeclampsia is associated with reduced serum levels of placenta growth factor // Am J Obstet Gynecol. 1998. – Vol. 179 – P. 1539–1544.

240.Turan S., Miller J., Baschat A.A. Integrated testing and management in fetal growth restriction // Semin Perinatol. – 2008. – Vol. 32 – №3 – P. 194-200.

241.Ultrasound and Fetal Growth. edited by J. M. Carrera, G. P. Mandruzzato and K. Maeda / 2001 The Parthenon Publishing Group

172

242.Unterscheider J., Daly S., Geary M.P., Kennelly M.M., McAuliffe F.M., O'Donoghue K., Hunter A., Morrison J.J., Burke G., Dicker P., Tully E.C., Malone F.D. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study // Am J Obstet Gynecol. 2013 – Vol. 208 – №4 – P. 290.e1-6.

243.Usher R., McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation // J Pediatr. 1969 – Vol. 74 – №6

–P. 901-910.

244.Vedmedovska N., Rezeberga D., Teibe U., Zodzika J., Donders G.G. Preventable maternal risk factors and association of genital infection with fetal growth restriction // Gynecol Obstet Invest. – 2010 – Vol. 70 – №4 – P. 291-298.

245.Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Baaqeel H., Farnot U., Bergsjø P., Bakketeig L., Lumbiganon P., Campodónico L., AlMazrou Y., Lindheimer M., Kramer M. World Health Organization Antenatal Care Trial Research Group. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? // Am J Obstet Gynecol. 2006. – Vol. 194 – №4 – P. 921-931.

246.Vintzileos A.M., Campbell W.A., Ingardia C.J., Nochimson D.J. The fetal biophysical profile and its predictive value. // Obstet Gynecol. – 1983

–Vol. 62 – № 3 – P. 271-8.

247.Voigt M., Olbertz D., Fusch C., Krafczyk D., Briese V., Schneider K.T. The influence of previous pregnancy terminations, miscarriages and still-births on the incidence of babies with low birth weight and premature births as well as a somatic classification of newborns // Z Geburtshilfe Neonatol. 2008 – Vol. 212 – №1 – P. 5-12.

248.Vuorela P., Hatva E., Lymboussaki A., Kaipainen A., Joukov V., Persico M.G., et al. Expression of vascular endothelial growth factor and placenta

173

growth factor in human placenta // Biol Reprod 1997 – Vol. 56 – №2 – P.

489–494.

249.Vuorela P., Hatva E., Lymboussaki A., Kaipainen A., Joukov V., Persico M.G., Alitalo K., Halmesmäki E. Expression of vascular endothelial growth factor and placenta growth factor in human placenta // Biol Reprod. 1997 – Vol. 56 – №2 – P. 489-494.

250.Vyas S., Nicolaides K.H., Bower S., Campbell S. Middle cerebral artery flow velocity waveforms in fetal hypoxaemia // Br J Obstet Gynaecol. 1990.

–Vol. 97 – №9 – P. 797-803.

251.Wallner W., Sengenberger R., Strick R., Strissel P.L., Meurer B., Beckmann M.W., Schlembach D. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction // Clin Sci (Lond). – 2007 – Vol. 112 – №1 – P. 51-57.

252.Walraven G.E., Mkanje R.J., van Roosmalen J., van Dongen P.W., van Asten A.G., Dolmans W.M. Single pre-delivery symphysis-fundal height measurement as a predictor of birthweight and multiple pregnancy // Br J Obstet Gynecol 1995 – Vol. 102 – P. 525–529.

253.Westerway S.C., Davison A., Cowell S. Ultrasonic fetal measurements: new Australian standards for the new millennium // Aust N Z J Obstet Gynaecol.

–2000 – Vol. 40 – №3 – P. 297-302.

254.Williams Obstetrics: 23rd Edition/F. Cunningham, Kenneth Leveno, Steven Bloom, John Hauth, Dwight Rouse, Catherine Spong/McGraw-Hill Professional Publishing 2009.

255.Winick M., Brasel J., Rosso P. Nutrition and cell growth // Nutrition and Development. New York: John Wiley – 1972.

256.World Health Organization. Aspects of low birth weight. Report of the Expert Comittee of maternal child health // WHO technical report – 1961 – Vol. 217 – P. 3–16.

174

257.Yamaguchi T.P., Rossant J. Fibroblast growth factors in mammalian development // Curr. Opin. Genet. Devel. – 1995 – Vol. 5 – P. 485–491.

175